Article Details

Primmune Therapeutics Presents Data from Phase 1 Study Evaluating PRTX007 in Healthy ...

Retrieved on: 2022-04-10 02:22:50

Tags for this article:

Click the tags to see associated articles and topics

Primmune Therapeutics Presents Data from Phase 1 Study Evaluating PRTX007 in Healthy .... View article details on hiswai:

Excerpt

... PRTX007 to be used in combination with immune checkpoint inhibitors— ... a biotech company harnessing the power of the innate immune system to ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up